129 filings
8-K
ITCI
Intra-Cellular Therapies Inc
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
8-K
ITCI
Intra-Cellular Therapies Inc
24 Apr 24
Other Events
4:20pm
8-K
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:40pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints
7:10am
8-K
3h7lxinmurd6m8lzaf89
1 Apr 24
Other Events
5:15pm
8-K
j2u6es4n3r4di4mx1c
19 Mar 24
Intra-cellular Therapies Announces Executive Appointments and Leadership Changes
8:44am
8-K
821img5s2d9pojqd7sy
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am
8-K
th2gub6o
2 Nov 23
Intra-cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
8:01am
8-K
zd1eznxct qhci8
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
8-K
vi8tc nd7jijo
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
vgwctn6q1y6fmxu6pgn0
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
8-K
0u4ru 8z54n8zfld
28 Mar 23
Other Events
7:12am
8-K
50oje79lg4 ehmatpyzd
1 Mar 23
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2022 Financial Results and Provides Corporate Update
7:41am
8-K
6yg5h8f8
9 Jan 23
Entry into a Material Definitive Agreement
5:13pm
8-K
9s7x sfe2bvnmq9l
22 Dec 22
Entry into a Material Definitive Agreement
4:09pm
8-K
2mgzeb7mjla0rk xb94
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
zyuax0
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
3f05luzzeuo0w1
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
ier 1olao4olqix
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am